MetLife Investment Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$110K Hold
2025
Q1
$148K Hold
2024
Q4
$282K Buy
2024
Q3
$233K Hold
2024
Q2
$208K Buy
2024
Q1
$166K Hold
2023
Q4
$176K Hold
2023
Q3
$185K Hold
2023
Q2
$177K Buy